Acumen Depreciation And Amortization from 2010 to 2025
| ABOS Stock | USD 1.88 0.06 3.09% |
Depreciation And Amortization | First Reported 2020-03-31 | Previous Quarter 44 K | Current Value 45 K | Quarterly Volatility 1.2 M |
Check Acumen Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Acumen Pharmaceuticals' main balance sheet or income statement drivers, such as Net Interest Income of 10.8 M, Interest Income of 15 M or Depreciation And Amortization of 169.1 K, as well as many indicators such as Price To Sales Ratio of 296, Dividend Yield of 0.0 or PTB Ratio of 0.6. Acumen financial statements analysis is a perfect complement when working with Acumen Pharmaceuticals Valuation or Volatility modules.
Acumen | Depreciation And Amortization | Build AI portfolio with Acumen Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.